|
C1ORF112 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.924300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.794100E-02 |
| Normal-vs-Stage2 |
1.072010E-01 |
| Normal-vs-Stage3 |
2.651900E-02 |
| Normal-vs-Stage4 |
9.425500E-02 |
| Stage1-vs-Stage2 |
3.457300E-03 |
| Stage1-vs-Stage3 |
2.905200E-01 |
| Stage1-vs-Stage4 |
4.656400E-01 |
| Stage2-vs-Stage3 |
1.176580E-03 |
| Stage2-vs-Stage4 |
6.043100E-03 |
| Stage3-vs-Stage4 |
9.524600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.527960E-02 |
| Normal-vs-AfricanAmerican |
2.117600E-01 |
| Normal-vs-Asian |
1.877170E-01 |
| Caucasian-vs-AfricanAmerican |
9.935400E-01 |
| Caucasian-vs-Asian |
7.252000E-01 |
| AfricanAmerican-vs-Asian |
8.202000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.905360E-01 |
| Normal-vs-Female |
9.274500E-02 |
| Male-vs-Female |
8.797000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.322100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.919190E-01 |
| Normal-vs-Age(61-80Yrs) |
5.915800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.655210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.901200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.429400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.463600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.912400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.610000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.965600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.239800E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
2.401800E-01 |
| Classical-VS-Normal |
2.556300E-04 |
| Tall-VS-Follicular |
2.84772205816353E-13 |
| Tall-VS-Other |
9.227600E-02 |
| Tall-VS-Normal |
3.229500E-04 |
| Follicular-VS-Other |
2.130300E-02 |
| Follicular-VS-Normal |
8.44350000028804E-07 |
| Other-VS-Normal |
8.912800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.567200E-01 |
| Normal-vs-N1 |
5.288100E-02 |
| N0-vs-N1 |
2.078300E-02 |
|
|
